Interwest Venture Management as of March 31, 2020
Portfolio Holdings for Interwest Venture Management
Interwest Venture Management holds 12 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Realreal (REAL) | 38.2 | $36M | 5.2M | 7.01 | |
| Glaukos (GKOS) | 33.0 | $31M | 1.0M | 30.86 | |
| Macrogenics (MGNX) | 6.6 | $6.3M | 1.1M | 5.82 | |
| Eiger Biopharmaceuticals | 5.5 | $5.2M | 765k | 6.80 | |
| Applied Genetic Technol Corp C | 5.0 | $4.8M | 1.5M | 3.28 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 3.5 | $3.4M | 1.4M | 2.48 | |
| Kalvista Pharmaceuticals (KALV) | 3.1 | $3.0M | 389k | 7.65 | |
| Venus Concept | 2.5 | $2.3M | 659k | 3.55 | |
| Neuronetics (STIM) | 2.1 | $1.9M | 1.0M | 1.89 | |
| Obalon Therapeutics | 0.3 | $274k | 380k | 0.72 | |
| Xenon Pharmaceuticals (XENE) | 0.1 | $94k | 8.3k | 11.33 | |
| Dare Bioscience (DARE) | 0.1 | $43k | 50k | 0.85 |
